Authors

Minesh Mehta, Miami Cancer InstituteFollow

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma

Publication Date

9-5-2024

Content Type

Article

PubMed ID:

38874333

Additional Authors:

Additional authors and institutional affiliations

Citation

Sloan, A. E., Winter, K., Gilbert, M. R., Aldape, K., Choi, S., Wen, P. Y., Butowski, N., Iwamoto, F. M., Raval, R. R., Voloschin, A. D., Kamiya-Matsuoka, C., Won, M., & Mehta, M. P. (2024). NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma. Neuro-oncology, 26(9), 1628–1637. https://doi.org/10.1093/neuonc/noae058